Rituximab is poised for growth due to its established use in oncology and autoimmune diseases, strong commercial history, and proven efficacy. Despite biosimilar competition, its broad indications and ...

The U.S. radiofrequency ablation devices market for pain management is set to expand due to rising chronic pain cases, demand for minimally invasive treatments, and a shift from opioids. Advancements ...

Objective To investigate the association between attention-deficit/hyperactivity disorder (ADHD) and cardiometabolic risk profile at the time of type 2 diabetes (T2D) diagnosis and examine ...

Objectives There is little consensus regarding the burden of pain in the UK. The purpose of this review was to synthesise existing data on the prevalence of various chronic pain phenotypes in order to ...